Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
MEDI1191 is an encapsulated mRNA formulation of interleukin-12 subunit beta (IL12B) and interleukin-12 subunit alpha (IL12A), which activate the immune system and prevent tumor cell proliferation (PMID: 32817076).
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Durvalumab + MEDI1191||Durvalumab MEDI1191||0||1|